Neuroprotective effects of 17β-estradiol rely on estrogen receptor membrane initiated signals

Frontiers in Physiology

Volumn 3 APR, Issue , 2012, Pages

  Fiocchetti, Marco ^a   Ascenzi, Paolo ^a   Marino, Maria ^a  

^a ROMA TRE UNIVERSITY   (Italy)

Author keywords

17 estradiol; Estrogen receptor ; Estrogen receptor ; Membrane initiated signals; Neuroprotective effects

Indexed keywords

EID: 84866330312     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2012.00073     Document Type: Review

References (159)

1. Acconcia, F., Ascenzi, P., Bocedi, A., Spisni, E., Tomasi, V., Trentalance, A., Visca, P., and Marino, M. (2005). Palmitoylation-dependent estrogen receptor α membrane localization: regulation by 17beta-estradiol. Mol. Biol. Cell 16, 231-237.
2. Acconcia, F., and Marino, M. (2011). The effects of 17β-estradiol in cancer are mediated by estrogen receptor signaling at the plasma membrane. Front. Physiol. 2:30. doi:10.3389/fphys.2011.00030
3. Adams, M. M., Fink, S. E., Janssen, W. G., Shah, R. A., and Morrison, J. H. (2004). Estrogen modulates synaptic N-methyl-D-aspartate receptor subunit distribution in the aged hippocampus. J. Comp. Neurol. 474, 419-426.
4. Amantea, D., Russo, R., Bagetta, G., and Corasaniti, M. T. (2005). From clinical evidence to molecular mechanisms underlying neuroprotection afforded by estrogens. Pharmacol. Res. 52, 119-132.
5. Amrein, I., Slomianka, L., Poletaeva, I., Bologova, N. V., and Lipp, H. P. (2004). Marked species and agedependent differences in cell proliferation and neurogenesis in the hippocampus of wild-living rodents. Hippocampus 14, 1000-1010.
6. Antal, M. C., Krust, A., Chambon, P., and Mark, M. (2008). Sterility and absence of histopathological defects in nonreproductive organs of a mouse ERβ-null mutant. Proc. Natl. Acad. Sci. U.S.A. 105, 2433-2438.
7. Arevalo, M. A., Santos-Galindo, M., Bellini, M. J.,Azcoitia, I., and Garcia-Segura, L. M. (2010). Actions of estrogens on glial cells: implications for neuroprotection. Biochim. Biophys. Acta 1800, 1106-1112.
8. Arnold, S., and Beyer, C. (2009). Neuroprotection by estrogen in the brain: the mitochondrial compartment as presumed therapeutic target. J. Neurochem. 110, 1-11.
9. Ascenzi, P., Bocedi, A., and Marino, M. (2006). Structure-function relationship of estrogen receptor α and β: impact on human health. Mol. Aspects Med. 27, 299-402.
10. Azcoitia, I.,Arevalo, M. A., De Nicola,A. F., and Garcia-Segura, L. M. (2011). Neuroprotective actions of estradiol revisited. Trends Endocrinol. Metab. 22, 467-473.
11. Ba, F., Pang, P. K., and Benishin, C. G. (2004a). The role of Ca2+ channel modulation in the neuroprotective actionsofestrogeninβ-amyloid protein and 1-methyl-4-phenyl1,2,3,6-tetrahydropyridine (MPTP) cytotoxic models. Neurochem. Int. 45, 31-38.
12. Ba, F., Pang, P. K., Davidge, S. T., and Benishin, C. G. (2004b). The neuroprotective effects of estrogen in SK-N-SH neuroblastoma cell cultures. Neurochem. Int. 44, 401-411.
13. Bae, Y. H., Hwang, J. Y., Kim, Y. H., and Koh,J.Y. (2000). Anti-oxidative neuroprotection by estrogens in mouse cortical cultures. J. Korean Med. Sci. 15, 327-336.
14. Bao, Y. J., Li, L. Z., Li, X. G., and Wang, Y. J. (2011). 17β-estradiol differentially protects cortical pericontusional zone from programmed cell death after traumatic cerebral contusion at distinct stages via nongenomic and genomic pathways. Mol. Cell. Neurosci. 48, 185-194.
15. Barha, C. K., and Galea, L. A. (2010). Influence of different estrogens on neuroplasticity and cognition in the hippocampus. Biochim. Biophys. Acta 1800, 1056-1067.
16. Bhavnani, B. R. (2003). Estrogens and menopause: pharmacology of conjugated equine estrogens and their potential role in the prevention of neurodegenerative diseases such as Alzheimer's. J. Steroid Biochem. Mol. Biol. 85, 473-482.
17. Bjornstrom, L., and Sjoberg, M. (2005). Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol. Endocrinol. 19, 833-842.
18. Bliss, T. V., and Collingridge, G. L. (1993). A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361, 31-39.
19. Bodo, C., and Rissman, E. F. (2006). New roles for estrogen receptor β in behavior and neuroendocrinology. Front. Neuroendocrinol. 27, 217-232.
20. Brannvall, K., Bogdanovic, N., Korhonen, L., and Lindholm, D. (2005). 19-Nortestosterone influences neural stem cell proliferation and neurogenesis in the rat brain. Eur. J. Neurosci. 21, 871-878.
21. Brannvall, K., Korhonen, L., and Lindholm, D. (2002). Estrogen-receptordependent regulation of neural stem cell proliferation and differentiation. Mol. Cell. Neurosci. 21, 512-520.
22. Breslau, N., Schultz, L., and Peterson, E. (1995). Sex differences in depression: a role for preexisting anxiety. Psychiatry Res. 58, 1-12.
23. Brunet, A., Datta, S. R., and Greenberg, M. E. (2001). Transcriptiondependent and-independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr. Opin. Neurobiol. 11, 297-305.
24. Burmester, T., and Hankeln, T. (2009). What is the function of neuroglobin? J. Exp. Biol. 212, 1423-1428.
25. Campbell, S., and Whitehead, M. (1977). Oestrogen therapy and the menopausal syndrome. Clin. Obstet. Gynaecol. 4, 31-47.
26. Carswell, H. V., Macrae, I. M., Gallagher, L., Harrop, E., and Horsburgh, K. J. (2004). Neuroprotection by a selective estrogen receptor β agonist in a mouse model of global ischemia. Am. J. Physiol. Heart Circ. Physiol. 287, H1501-H1504.
27. Chambard, J. C., Lefloch, R., Pouyssegur, J., and Lenormand, P. (2007). ERK implication in cell cycle regulation. Biochim. Biophys. Acta 1773, 1299-1310.
28. Chen, Z. J., Yu, L., and Chang, C. H. (1998). Stimulation of membranebound guanylate cyclase activity by 17-β estradiol. Biochem. Biophys. Res. Commun. 252, 639-642.
29. De Marinis, E., Ascenzi, P., Pellegrini, M.,Galluzzo,P.,Bulzomi,P.,Arevalo, M. A., Garcia-Segura, L. M., and Marino, M. (2010). 17β-estradiol-A new modulator of neuroglobin levels in neurons: role in neuroprotection against H2O2-induced toxicity. Neurosignals 18, 223-235.
30. De Marinis,E.,Marino,M.,and Ascenzi, P. (2011). Neuroglobin, estrogens, and neuroprotection. IUBMB Life 63, 140-145.
31. DellaValle, B., Hempel, C., Kurtzhals, J. A., and Penkowa, M. (2010). In vivo expression of neuroglobin in reactive astrocytes during neuropathol-ogy in murine models of traumatic brain injury, cerebral malaria, and autoimmune encephalitis. Glia 58, 1220-1227.
32. Demars, M., Hu,Y. S., Gadadhar,A., and Lazarov, O. (2010). Impaired neurogenesis is an early event in the etiology of familial Alzheimer's disease in transgenic mice. J. Neurosci. Res. 88, 2103-2117.
33. DonCarlos, L. L., Azcoitia, I., and Garcia-Segura, L. M. (2009). Neuroprotective actions of selective estrogen receptor modulators. Psychoneuroendocrinology 34(Suppl. 1), S113-S122.
34. Donzelli, A., Braida, D., Finardi, A., Capurro, V., Valsecchi, A. E., Colleoni, M., and Sala, M. (2010). Neuroprotective effects of genistein in Mongolian gerbils: estrogen receptor-β involvement. J. Pharmacol. Sci. 114, 158-167.
35. Dubal, D. B., Zhu, H., Yu, J., Rau, S. W., Shughrue, P. J., Merchenthaler, I., Kindy, M. S., and Wise, P. M. (2001). Estrogen receptor alpha, not beta, is a critical link in estradiolmediated protection against brain injury. Proc. Natl. Acad. Sci. U.S.A. 98, 1952-1957.
36. Eriksson, P. S., Perfilieva, E., Bjork-Eriksson, T., Alborn, A. M., Nordborg, C., Peterson, D. A., and Gage, F. H. (1998). Neurogenesis in the adult human hippocampus. Nat. Med. 4, 1313-1317.
37. Etgen, A. M., Jover-Mengual, T., and Zukin, R. S. (2011). Neuroprotective actions of estradiol and novel estrogen analogs in ischemia: translational implications. Front. Neuroendocrinol. 32, 336-352.
38. Fago, A., Mathews, A. J., and Brittain, T. (2008). A role for neuroglobin: resetting the trigger level for apoptosis in neuronal and retinal cells. IUBMB Life 60, 398-401.
39. Farach-Carson, M. C., and Davis, P. J. (2003). Steroid hormone interactions with target cells: cross talk between membrane and nuclear pathways. J. Pharmacol. Exp. Ther. 307, 839-845.
40. Filardo, E., Quinn, J., Pang, Y., Grae-ber, C., Shaw, S., Dong, J., and Thomas, P. (2007). Activation of the novel estrogen receptor G proteincoupled receptor 30 (GPR30) at the plasma membrane. Endocrinology 148, 3236-3245.
41. Fitzpatrick, J. L., Mize, A. L., Wade, C. B., Harris, J. A., Shapiro, R. A., and Dorsa, D. M. (2002). Estrogenmediated neuroprotection against beta-amyloid toxicity requires expression of estrogen receptor alpha or beta and activation of the MAPK pathway. J. Neurochem. 82, 674-682.
42. Fried, G., Andersson, E., Csoregh, L., Enmark, E., Gustafsson, J. A., Aanesen, A., and Osterlund, C. (2004). Estrogen receptor beta is expressed in human embryonic brain cells and is regulated by 17beta-estradiol. Eur. J. Neurosci. 20, 2345-2354.
43. Galluzzo, P., Caiazza, F., Moreno, S., and Marino, M. (2007). Role of ERβ palmitoylation in the inhibition of human colon cancer cell proliferation. Endocr. Relat. Cancer 14, 153-167.
44. Garcia-Segura, L. M., Azcoitia, I., and Doncarlos, L. L. (2001). Neuroprotection by estradiol. Prog. Neurobiol. 63, 29-60.
45. Garcia-Segura, L. M., Duenas, M., Fernandez-Galaz, M. C., Chowen, J. A., Argente, J., Naftolin, F., and Torres-Aleman, I. (1996). Interaction of the signalling pathways of insulin-like growth factorI and sex steroids in the neuroendocrine hypothalamus. Horm. Res. 46, 160-164.
46. Gillies, G. E., and McArthur, S. (2010). Estrogen actions in the brain and the basis for differential action in men and women: a case for sexspecific medicines. Pharmacol. Rev. 62, 155-198.
47. Gosden, J. R., Middleton, P. G., and Rout, D. (1986). Localization of the human oestrogen receptor gene to chromosome 6q24-q27 by in situ hybridization. Cytogenet. Cell Genet. 43, 218-220.
48. Gould, E., Mcewen, B. S., Tanapat, P., Galea, L. A., and Fuchs, E. (1997). Neurogenesis in the dentate gyrus of the adult tree shrew is regulated by psychosocial stress and NMDA receptor activation. J. Neurosci. 17, 2492-2498.
49. Gould, E., Vail, N., Wagers, M., and Gross, C. G. (2001). Adult-generated hippocampal and neocortical neurons in macaques have a transient existence. Proc. Natl. Acad. Sci. U.S.A. 98, 10910-10917.
50. Green, A. D., and Galea, L. A. (2008). Adult hippocampal cell proliferation is suppressed with estrogen withdrawal after a hormonesimulated pregnancy. Horm. Behav. 54, 203-211.
51. Gu, Q., and Moss, R. L. (1996). 17β-estradiol potentiates kainateinduced currents via activation of the cAMP cascade. J. Neurosci. 16, 3620-3629.
52. Guerra, B., Diaz, M., Alonso, R., and Marin, R. (2004). Plasma membrane oestrogen receptor mediates neuroprotection against betaamyloid toxicity through activation of Raf-1/MEK/ERK cascade in septal-derived cholinergic SN56 cells. J. Neurochem. 91, 99-109.
53. Gupta, R. R., Sen, S., Diepenhorst, L. L., Rudick, C. N., and Maren, S. (2001). Estrogen modulates sexually dimorphic contextual fear conditioning and hippocampal long-term potentiation (LTP) in rats(1). Brain Res. 888, 356-365.
54. Halbreich, U. (1997). Role of estrogen in postmenopausal depression. Neurology 48, S16-S19.
55. Hammes, S. R., and Levin, E. R. (2007). Extranuclear steroid receptors: nature and actions. Endocr. Rev. 28, 726-741.
56. Hampson, E., and Kimura, D. (1988). Reciprocal effects of hormonal fluctuations on human motor and perceptual-spatial skills. Behav. Neurosci. 102, 456-459.
57. Handa, R. J., Ogawa, S., Wang, J. M., and Herbison, A. E. (2010). Roles for estrogen receptor β in adult brain function. J. Neuroendocrinol. 24, 160-173.
58. Hata, T., Furukawa, T., Sunamura, M., Egawa, S., Motoi, F., Ohmura, N., Marumoto, T., Saya, H., and Horii, A. (2005). RNA interference targeting Aurora kinase a suppresses tumor growth and enhances the taxane chemosensitivity in human pancreatic cancer cells. Cancer Res. 65, 2899-2905.
59. Herrera, J. L., Fernandez, C., Diaz, M., Cury, D., and Marin, R. (2011). Estradiol and tamoxifen differentially regulate a plasmalemmal voltage-dependent anion channel involved in amyloid-β induced neurotoxicity. Steroids 76, 840-844.
60. Hileman, S. M., Handa, R. J., and Jackson, G. L. (1999). Distribution of estrogen receptor-β messenger ribonucleic acid in the male sheep hypothalamus. Biol. Reprod. 60, 1279-1284.
61. Hong, S. H., Nah, H. Y., Lee, Y. J., Lee, J. W., Park, J. H., Kim, S. J., Lee, J. B., Yoon, H. S., and Kim, C. H. (2004). Expression of estrogen receptor-α and -β, glucocorticoid receptor, and progesterone receptor genes in human embryonic stem cells and embryoid bodies. Mol. Cells 18, 320-325.
62. Huhtaniemi, I. (1994). Fetal testis-a very special endocrine organ. Eur. J. Endocrinol. 130, 25-31.
63. Inagaki, T., Gautreaux, C., and Luine, V. (2010). Acute estrogen treatment facilitates recognition memory consolidation and alters monoamine levels in memory-related brain areas. Horm. Behav. 58, 415-426.
64. Irwin, R. W., Yao, J., Hamilton, R. T., Cadenas, E., Brinton, R. D., and Nilsen, J. (2008). Progesterone and estrogen regulate oxidative metabolism in brain mitochondria. Endocrinology 149, 3167-3175.
65. Jacome, L. F., Gautreaux, C., Inagaki, T., Mohan, G., Alves, S., Lubbers, L. S., and Luine, V. (2010). Estradiol and ERbeta agonists enhance recognition memory, and DPN, an ERβ agonist, alters brain monoamines. Neurobiol. Learn. Mem. 94, 488-498.
66. Kalaitzidis, D., and Gilmore, T. D. (2005). Transcription factor crosstalk: the estrogen receptor and NFκB. Trends Endocrinol. Metab. 16, 46-52.
67. Kelly, M. J., and Levin, E. R. (2001). Rapid actions of plasma membrane estrogen receptors. Trends Endocrinol. Metab. 12, 152-156.
68. Kelly, M. J., Loose, M. D., and Ronnekleiv, O. K. (1992). Estrogen suppresses μ-opioidand GABABmediated hyperpolarization of hypothalamic arcuate neurons. J. Neurosci. 12, 2745-2750.
69. Kessler,R. C.,Mcgonagle,K. A.,Zhao,S., Nelson,C. B.,Hughes,M.,Eshleman, S., Wittchen, H. U., and Kendler, K. S. (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch. Gen. Psychiatry 51, 8-19.
70. Kindy, M. S. (1993). Inhibition of tyrosine phosphorylation prevents delayed neuronal death following cerebral ischemia. J. Cereb. Blood Flow Metab. 13, 372-377.
71. Kudwa, A. E., Michopoulos, V., Gatewood, J. D., and Rissman, E. F. (2006). Roles of estrogen receptors α and β in differentiation of mouse sexual behavior. Neuroscience 138, 921-928.
72. Kuiper, G. G., Carlsson, B., Grandien, K., Enmark, E., Haggblad, J., Nilsson, S., and Gustafsson, J. A. (1997). Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 138, 863-870.
73. Kuroki, Y., Fukushima, K., Kanda, Y., Mizuno, K., and Watanabe, Y. (2001). Neuroprotection by estrogen via extracellular signal-regulated kinase against quinolinic acidinduced cell death in the rat hippocampus. Eur. J. Neurosci. 13, 472-476.
74. Laflamme, N., Nappi, R. E., Drolet, G., Labrie, C., and Rivest, S. (1998). Expression and neuropeptidergic characterization of estrogen receptors (ERα and ERβ) throughout the rat brain: anatomical evidence of distinct roles of each subtype. J. Neurobiol. 36, 357-378.
75. Lagrange, A. H., Ronnekleiv, O. K., and Kelly, M. J. (1997). Modulation of G protein-coupled receptors by an estrogen receptor that activates protein kinase A. Mol. Pharmacol. 51, 605-612.
76. Lee, S. J., Campomanes, C. R., Sikat, P. T., Greenfield, A. T., Allen, P. B., and Mcewen, B. S. (2004). Estrogen induces phosphorylation of cyclic AMP response element binding (pCREB) in primary hippocampal cells in a time-dependent manner. Neuroscience 124, 549-560.
77. Levin, E. R. (2005). Integration of the extranuclear and nuclear actions of estrogen. Mol. Endocrinol. 19, 1951-1959.
78. Liu, F., Day, M., Muniz, L. C., Bitran, D., Arias, R., Revilla-Sanchez, R., Grauer, S., Zhang, G., Kelley, C., Pulito, V., Sung, A., Mervis, R. F., Navarra, R., Hirst, W. D., Reinhart, P. H., Marquis, K. L., Moss, S. J., Pangalos, M. N., and Brandon,N. J. (2008).Activation of estrogen receptor-β regulates hippocampal synaptic plasticity and improves memory. Nat. Neurosci. 11, 334-343.
79. Luine, V. N. (2008). Sex steroids and cognitive function. J. Neuroendocrinol. 20, 866-872.
80. Luisi, S., Galleri, L., Marini, F., Ambrosini, G., Brandi, M. L., and Petraglia, F. (2006). Estrogen receptor gene polymorphisms are associated with recurrence of endometriosis. Fertil. Steril. 85, 764-766.
81. Maggi, A., Ciana, P., Belcredito, S., and Vegeto, E. (2004). Estrogens in the nervous system: mechanisms and nonreproductive functions. Annu. Rev. Physiol. 66, 291-313.
82. Malberg, J. E., and Duman, R. S. (2003). Cell proliferation in adult hippocampus is decreased by inescapable stress: reversal by fluoxetine treatment. Neuropsychopharmacology 28, 1562-1571.
83. Malenka, R. C., and Bear, M. F. (2004). LTP and LTD: an embarrassment of riches. Neuron 44, 5-21.
84. Malinow, R., and Malenka, R. C. (2002). AMPA receptor trafficking and synaptic plasticity. Annu. Rev. Neurosci. 25, 103-126.
85. Malyala, A., Kelly, M. J., and Ronnekleiv, O. K. (2005). Estrogen modulation of hypothalamic neurons: activation of multiple signaling pathways and gene expression changes. Steroids 70, 397-406.
86. Marin, R., Diaz, M., Alonso, R., Sanz, A., Arevalo, M.A., and Garcia-Segura,L. M. (2009). Role of estrogen receptor α in membrane-initiated signaling in neural cells: interaction with IGF1receptor.J. Steroid Biochem. Mol. Biol. 114, 2-7.
87. Marin, R., Ramirez, C. M., Gonzalez, M., Gonzalez-Munoz, E., Zorzano, A., Camps, M., Alonso, R., and Diaz, M. (2007). Voltage-dependent anion channel (VDAC) participates in amyloid β-induced toxicity and interacts with plasma membrane estrogen receptor α in septal and hippocampal neurons. Mol. Membr. Biol. 24, 148-160.
88. Marino, M., and Ascenzi, P. (2008). Membrane association of estrogen receptor α and β influences 17βestradiol-mediated cancer cell proliferation. Steroids 73, 853-858.
89. Marquez, D. C., Chen, H. W., Curran, E. M.,Welshons,W.V., and Pietras, R. J. (2006). Estrogen receptors in membrane lipid rafts and signal transduction in breast cancer. Mol. Cell. Endocrinol. 246, 91-100.
90. McEwen, B. (2002). Estrogen actions throughout the brain. Recent Prog. Horm. Res. 57, 357-384.
91. Metivier, R., Penot, G., Hubner, M. R., Reid, G., Brand, H., Kos, M., and Gannon, F. (2003). Estrogen receptor-α directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115, 751-763.
92. Mitra, S. W., Hoskin, E., Yudkovitz, J., Pear, L., Wilkinson, H. A., Hayashi, S., Pfaff, D. W., Ogawa, S., Rohrer, S. P., Schaeffer, J. M., Mcewen, B. S., and Alves, S. E. (2003). Immunolocalization of estrogen receptor β in the mouse brain: comparison with estrogen receptor α. Endocrinology 144, 2055-2067.
93. Morgan, M. A., and Pfaff, D. W. (2001). Effects of estrogen on activity and fear-related behaviors in mice. Horm. Behav. 40, 472-482.
94. Morgan, M. A., and Pfaff, D. W. (2002). Estrogen's effects on activity, anxiety, and fear in two mouse strains. Behav. Brain. Res. 132, 85-93.
95. Morissette, M., Le Saux, M., D'Astous, M., Jourdain, S.,Al Sweidi, S., Morin, N., Estrada-Camarena, E., Mendez, P., Garcia-Segura, L. M., and Di Paolo, T. (2008). Contribution of estrogen receptors α and β to the effects of estradiol in the brain. J. Steroid Biochem. Mol. Biol. 108, 327-338.
96. Murphy, D. D., and Segal, M. (1996). Regulation of dendritic spine density in cultured rat hippocampal neurons by steroid hormones. J. Neurosci. 16, 4059-4068.
97. Murphy, D. D., and Segal, M. (1997). Morphological plasticity of dendritic spines in central neurons is mediated by activation of cAMP response element binding protein. Proc. Natl. Acad. Sci. U.S.A. 94, 1482-1487.
98. Nilsson, S., and Gustafsson, J. A. (2011). Estrogen receptors: therapies targetedtoreceptorsubtypes.Clin. Pharmacol. Ther. 89, 44-55.
99. Numakawa, T., Matsumoto, T., Numakawa, Y., Richards, M., Yamawaki, S., and Kunugi, H. (2011). Protective action of neurotrophic factors and estrogen against oxidative stress-mediated neurodegeneration. J. Toxicol. 2011, 405194.
100. Ogawa, S., Eng, V., Taylor, J., Lubahn, D. B., Korach, K. S., and Pfaff, D. W. (1998). Roles of estrogen receptorα gene expression in reproductionrelated behaviors in female mice. Endocrinology 139, 5070-5081.
101. O'Lone, R., Frith, M. C., Karlsson, E. K., and Hansen, U. (2004). Genomic targets of nuclear estrogen receptors. Mol. Endocrinol. 18, 1859-1875.
102. Osterlund, M. K., Grandien, K., Keller, E., and Hurd, Y. L. (2000a). The human brain has distinct regional expression patterns of estrogen receptor α mRNA isoforms derived from alternative promoters. J. Neurochem. 75, 1390-1397.
103. Osterlund, M. K., Gustafsson, J. A., Keller, E., and Hurd, Y. L. (2000b). Estrogen receptor beta ERβ) messenger ribonucleic acid (mRNA) expression within the human forebrain: distinct distribution pattern to ERα mRNA. J. Clin. Endocrinol. Metab. 85, 3840-3846.
104. Osterlund, M. K., Keller, E., and Hurd, Y. L. (2000c). The human forebrain has discrete estrogen receptor α messenger RNA expression: high levels in the amygdaloid complex. Neuroscience 95, 333-342.
105. Pedram, A., Razandi, M., Sainson, R. C., Kim, J. K., Hughes, C. C., and Levin, E. R. (2007). A conserved mechanism for steroid receptor translocation to the plasma membrane. J. Biol. Chem. 282, 22278-22288.
106. Pettersson, K., and Gustafsson, J. A. (2001). Role of estrogen receptor β in estrogen action. Annu. Rev. Physiol. 63, 165-192.
107. Pfaff, D. W., Schwanzel-Fukuda, M., Parhar, I. S., Lauber, A. H., Mccarthy, L. M., and Kow, L. M. (1994). GnRH neurons and other cellular and molecular mechanisms for simple mammalian reproductive behaviors. Recent Prog. Horm. Res. 49, 1-25.
108. Phillips, S. M., and Sherwin, B. B. (1992). Variations in memory function and sex steroid hormones across the menstrual cycle. Psychoneuroendocrinology 17, 497-506.
109. Picard, N., Charbonneau, C., Sanchez, M., Licznar, A., Busson, M., Lazennec, G., and Tremblay, A. (2008). Phosphorylation of activation function-1 regulates proteasomedependent nuclear mobility and E6-associated protein ubiquitin ligase recruitment to the estrogen receptor β. Mol. Endocrinol. 22, 317-330.
110. Prossnitz, E. R., and Barton, M. (2011). The G-protein-coupled estrogen receptor GPER in health and disease. Nat. Rev. Endocrinol. 7, 715-726.
111. Raz, L., Khan, M. M., Mahesh, V. B., Vadlamudi, R. K., and Brann, D. W. (2008). Rapid estrogen signaling in the brain. Neurosignals 16, 140-153.
112. Razandi, M., Alton, G., Pedram, A., Ghonshani, S., Webb, P., and Levin, E. R. (2003). Identification of a structural determinant necessary for the localization and function of estrogen receptor α at the plasma membrane. Mol. Cell. Biol. 23, 1633-1646.
113. Razmara, A., Duckles, S. P., Krause, D. N., and Procaccio, V. (2007). Estrogen suppresses brain mitochondrial oxidative stress in female and male rats. Brain Res. 1176, 71-81.
114. Reid, G., Hubner, M. R., Metivier, R., Brand, H., Denger, S., Manu, D., Beaudouin, J., Ellenberg, J., and Gannon, F. (2003). Cyclic, proteasome-mediated turnover of unliganded and liganded ERα on responsive promoters is an integral feature of estrogen signaling. Mol. Cell 11, 695-707.
115. Rhodes, M. E., and Frye, C. A. (2004). Estrogen has mnemonic-enhancing effects in the inhibitory avoidance task. Pharmacol. Biochem. Behav. 78, 551-558.
116. Rocha, B. A., Fleischer, R., Schaeffer, J. M., Rohrer, S. P., and Hickey, G. J. (2005). 17β-estradiolinduced antidepressant-like effect in the forced swim test is absent in estrogen receptor-β knockout (BERKO) mice. Psychopharmacology (Berl.) 179, 637-643.
117. Rodriguez, J. J., Jones, V. C., Tabuchi, M., Allan, S. M., Knight, E. M., Laferla, F. M., Oddo, S., and Verkhratsky, A. (2008). Impaired adult neurogenesis in the dentate gyrus of a triple transgenic mouse model of Alzheimer's disease. PLoS ONE 3, e2935. doi:10.1371/journal.pone.0002935
118. Roepke, T. A., Qiu, J., Bosch, M. A., Ronnekleiv, O. K., and Kelly, M. J. (2009). Cross-talk between membrane-initiated and nuclearinitiated oestrogen signalling in the hypothalamus. J. Neuroendocrinol. 21, 263-270.
119. Roepke, T. A., Ronnekleiv, O. K., and Kelly, M. J. (2011). Physiological consequences of membraneinitiated estrogen signaling in the brain. Front. Biosci. 16, 1560-1573.
120. Ronnekleiv, O. K., and Kelly, M. J. (2005). Diversity of ovarian steroid signaling in the hypothalamus. Front. Neuroendocrinol. 26, 65-84.
121. Sampei, K., Goto, S., Alkayed, N. J., Crain, B. J., Korach, K. S., Traystman, R. J., Demas, G. E., Nelson, R. J., and Hurn, P. D. (2000). Stroke in estrogen receptor-α-deficient mice. Stroke 31, 738-743.
122. Sawai, T., Bernier, F., Fukushima, T., Hashimoto, T., Ogura, H., and Nishizawa, Y. (2002). Estrogen induces a rapid increase of calcium-calmodulin-dependent protein kinase II activity in the hippocampus. Brain Res. 950, 308-311.
123. Schneier, F. R., Johnson, J., Hornig, C. D., Liebowitz, M. R., and Weissman, M. M. (1992). Social phobia. Comorbidity and morbidity in an epidemiologic sample. Arch. Gen. Psychiatry 49, 282-288.
124. Schreihofer, D. A., Do, K. D., and Schreihofer, A. M. (2005). Highsoy diet decreases infarct size after permanent middle cerebral artery occlusion in female rats. Am.J.Physiol. Regul. Integr. Comp. Physiol. 289, R103-R108.
125. Seeman, M. V. (1997). Psychopathol-ogy in women and men: focus on female hormones. Am. J. Psychiatry 154, 1641-1647.
126. Sherwin, B. B. (2005). Surgical menopause, estrogen, and cognitive function in women: what do the findings tell us? Ann. N. Y. Acad. Sci. 1052, 3-10.
127. Shughrue, P. J., Komm, B., and Merchenthaler, I. (1996). The distribution of estrogen receptor-β mRNA in the rat hypothalamus. Steroids 61, 678-681.
128. Shughrue, P. J., Scrimo, P. J., and Merchenthaler, I. (1998). Evidence for the colocalization of estrogen receptor-β mRNA and estrogen receptor-β immunoreactivity in neurons of the rat forebrain. Endocrinology 139, 5267-5270.
129. Simpkins, J. W., and Dykens, J. A. (2008). Mitochondrial mechanisms of estrogen neuroprotection. Brain. Res. Rev. 57, 421-430.
130. Smith, C. C., and McMahon, L. L. (2006). Estradiol-induced increase in the magnitude of long-term potentiation is prevented by blocking NR2B-containing receptors. J. Neurosci. 26, 8517-8522.
131. Squires, M. S., Nixon, P. M., and Cook, S. J. (2002). Cell-cycle arrest by PD184352 requires inhibition of extracellular signal-regulated kinases (ERK) 1/2 but not ERK5/BMK1. Biochem. J. 366, 673-680.
132. Sribnick, E. A., Ray, S. K., Nowak, M. W., Li, L., and Banik, N. L. (2004). 17β-estradiol attenuates glutamateinduced apoptosis and preserves electrophysiologic function in primary cortical neurons. J. Neurosci. Res. 76, 688-696.
133. Suzuki, S., Brown, C. M., and Wise, P. M. (2006). Mechanisms of neuroprotection by estrogen. Endocrine 29, 209-215.
134. Suzuki, S., Gerhold, L. M., Bottner, M., Rau, S. W., Dela Cruz, C., Yang, E., Zhu, H.,Yu, J., Cashion, A. B., Kindy, M. S., Merchenthaler, I., Gage, F. H., and Wise, P. M. (2007). Estradiol enhances neurogenesis following ischemic stroke through estrogen receptors α and β. J. Comp. Neurol. 500, 1064-1075.
135. Szego, C. M., and Davis, J. S. (1967). Adenosine 3',5'-monophosphate in rat uterus: acute elevation by estrogen. Proc. Natl. Acad. Sci. U.S.A. 58, 1711-1718.
136. Tanapat, P., Hastings, N. B., and Gould, E. (2005). Ovarian steroids influence cell proliferation in the dentate gyrus of the adult female rat in a doseand time-dependent manner. J. Comp. Neurol. 481, 252-265.
137. Tanapat, P., Hastings, N. B., Reeves, A. J., and Gould, E. (1999). Estrogen stimulates a transient increase in the number of new neurons in the dentate gyrus of the adult female rat. J. Neurosci. 19, 5792-5801.
138. Toran-Allerand, C. D., Guan, X., Maclusky, N. J., Horvath, T. L., Diano, S., Singh, M., Connolly, E. S. Jr., Nethrapalli, I. S., and Tinnikov, A. A. (2002). ER-X: a novel, plasma membrane-associated, putative estrogen receptor that is regulated during development and after ischemic brain injury. J. Neurosci. 22, 8391-8401.
139. Trieu, V. N., Dong, Y., Zheng, Y., and Uckun, F. M. (1999). In vivo antioxidant activity of genistein in a murine model of singlet oxygen-induced cerebral stroke. Radiat. Res. 152, 508-516.
140. Ussar, S., and Voss, T. (2004). MEK1 and MEK2, different regulators of the G1/S transition. J. Biol. Chem. 279, 43861-43869.
141. Vasudevan, N., and Pfaff, D. W. (2007). Membrane-initiated actions of estrogens in neuroendocrinology: emerging principles. Endocr. Rev. 28, 1-19.
142. Vollmayr, B., Simonis, C., Weber, S., Gass, P., and Henn, F. (2003). Reduced cell proliferation in the dentate gyrus is not correlated with the development of learned helplessness. Biol. Psychiatry 54, 1035-1040.
143. Wade, C. B., and Dorsa, D. M. (2003). Estrogen activation of cyclic adenosine 5'-monophosphate response element-mediated transcription requires the extracellularly regulated kinase/mitogen-activated protein kinase pathway. Endocrinology 144, 832-838.
144. Walf, A. A., and Frye, C. A. (2006). A review and update of mechanisms of estrogen in the hippocampus and amygdala for anxiety and depression behavior. Neuropsychopharmacology 31, 1097-1111.S
145. Walf, A. A., and Frye, C. A. (2007). Administration of estrogen receptor β-specific selective estrogen receptor modulators to the hippocampus decrease anxiety and depressive behavior of ovariectomized rats. Pharmacol. Biochem. Behav. 86, 407-414.
146. Walf,A. A.,and Frye,C. A. (2008). Rapid and estrogen receptor beta mediated actions in the hippocampus mediate some functional effects of estrogen. Steroids 73, 997-1007.
147. Wang, J. M., Irwin, R. W., Liu, L., Chen, S., and Brinton, R. D. (2007). Regeneration in a degenerating brain: potential of allopregnanolone as a neuroregenerative agent. Curr. Alzheimer Res. 4, 510-517.
148. Wang, J. M., Liu, L., and Brinton, R. D. (2008). Estradiol-17beta-induced human neural progenitor cell proliferation is mediated by an estrogen receptor β-phosphorylated extracellularly regulated kinase pathway. Endocrinology 149, 208-218.
149. Wang, J. M., Singh, C., Liu, L., Irwin, R. W., Chen, S., Chung, E. J., Thompson, R. F., and Brinton, R. D. (2010). Allopregnanolone reverses neurogenic and cognitive deficits in mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 107, 6498-6503.
150. Wang, S., Ren, P., Li, X., Guan, Y., and Zhang, Y. A. (2011). 17β-estradiol protects dopaminergic neurons in organotypic slice of mesencephalon by MAPK-mediated activation of anti-apoptosis Gene BCL2. J. Mol. Neurosci. 45, 236-245.
151. Wang, X., Dykens, J. A., Perez, E., Liu, R., Yang, S., Covey, D. F., and Simpkins, J. W. (2006). Neuroprotective effects of 17β-estradiol and nonfeminizing estrogens against H2O2 toxicity in human neuroblastoma SK-N-SH cells. Mol. Pharmacol. 70, 395-404.
152. Watson, C. S., Alyea, R. A., Cunningham, K. A., and Jeng, Y. J. (2010). Estrogens of multiple classes and their role in mental health disease mechanisms. Int. J. Womens Health 2, 153-166.
153. Weiser, M. J., Foradori, C. D., and Handa, R. J. (2008). Estrogen receptor β in the brain: from form to function. Brain. Res. Rev. 57, 309-320.
154. Weiser, M. J., Wu, T. J., and Handa, R. J. (2009). Estrogen receptor-β agonist diarylpropionitrile: biological activities of Rand S-enantiomers on behavior and hormonal response to stress. Endocrinology 150, 1817-1825.
155. Wise, P. M., Dubal, D. B., Wilson, M. E., Rau, S. W., and Liu, Y. (2001). Estrogens: trophic and protective factors in the adult brain. Front. Neuroendocrinol. 22, 33-66.
156. Woolley, C. S. (2007). Acute effects of estrogen on neuronal physiology. Annu. Rev. Pharmacol. Toxicol. 47, 657-680.
157. Yu, Z., Fan, X., Lo, E. H., and Wang, X. (2009). Neuroprotective roles and mechanisms of neuroglobin. Neurol. Res. 31, 122-127.
158. Zaulyanov, L. L., Green, P. S., and Simpkins, J. W. (1999). Glutamate receptor requirement for neuronal death from anoxia-reoxygenation: an in vitro model for assessment of the neuroprotective effects of estrogens. Cell.Mol.Neurobiol.19, 705-718.
159. Zhou, W., Liu, Z., Wu, J., Liu, J. H., Hyder, S. M., Antoniou, E., and Lubahn, D. B. (2006). Identification and characterization of two novel splicing isoforms of human estrogen-related receptor β. J. Clin. Endocrinol. Metab. 91, 569-579.